Related content

A double-blind placebo controlled experimental study of nicotine: I—effects on incentive motivation

By Dawkins Lynne   Powell Jane   West Robert   Powell John   Pickering Alan  

Psychopharmacology, Vol. 189, Iss. 3, 2006-12 ,pp. : 355-367

Springer Publishing Company

Access to resources Recommend Favorite

Nicotine and Behavioral Markers of Risk for Schizophrenia - A Double-Blind, Placebo-Controlled, Cross-Over Study

By Depatie L.   O'Driscoll G.A.   Holahan A.-L.V.   Atkinson V.   Thavundayil J.X.   Kin N.N.Y.   Lal S.  

Neuropsychopharmacology, Vol. 27, Iss. 6, 2002-12 ,pp. : 1056-1070

Elsevier

Access to resources Recommend Favorite

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study

By Boér Katalin  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 681-687

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Tolerability of Irbesartan, an Angiotensin II Receptor Antagonist, in Primary Hypertension: A Double-Blind, Placebo-Controlled, Dose-Titration Study

By Guthrie R.  

Clinical Drug Investigation, Vol. 15, Iss. 3, 1998-03 ,pp. : 217-227

Adis International

Access to resources Recommend Favorite

Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study

By Alhaj Hamid   Massey Anna   McAllister-Williams R.  

Psychopharmacology, Vol. 188, Iss. 4, 2006-11 ,pp. : 541-551

Springer Publishing Company

Access to resources Recommend Favorite